Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer. (Q53144257)
Jump to navigation
Jump to search
scientific article published in June 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer. |
scientific article published in June 2008 |
Statements
Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer (English)
Corey J Langer
Kenneth J O'Byrne
Mark A Socinski
Sergei M Mikhailov
Krzysztof Leśniewski-Kmak
Tudor E Ciuleanu
Mircea Dediu
David Heigener
Amy J Eisenfeld
Larissa Sandalic
Fred B Oldham